tocophersolan has been researched along with methylcellulose in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 7 (87.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goddeeris, C; Van den Mooter, G; Willems, T | 1 |
Bose, S; Ghosh, I; Harmon, F; Vippagunta, R | 1 |
Balakrishnan, P; Cho, HJ; Chung, SJ; Kim, DD; Shim, CK | 1 |
Ghosh, I; Michniak-Kohn, B | 2 |
George, M; Ghosh, I | 1 |
Cha, KH; Cho, W; Hwang, SJ; Kim, JS; Kim, MS; Park, HJ; Park, J | 1 |
McKelvey, C; Moser, J; Rege, B; Sotthivirat, S; Xu, W; Zhang, D | 1 |
8 other study(ies) available for tocophersolan and methylcellulose
Article | Year |
---|---|
Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781.
Topics: Anilides; Anti-HIV Agents; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Furans; Hypromellose Derivatives; Kinetics; Methylcellulose; Models, Chemical; Polyethylene Glycols; Povidone; Pyrrolidines; Solubility; Tablets; Technology, Pharmaceutical; Thermodynamics; Thioamides; Transition Temperature; Vinyl Compounds; Vitamin E | 2008 |
Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth.
Topics: Animals; Benzodiazepinones; Biological Availability; Crystallization; Dogs; Drug Carriers; Drug Stability; Excipients; Hydrophobic and Hydrophilic Interactions; Hypromellose Derivatives; Male; Methylcellulose; Nanoparticles; Particle Size; Phenylurea Compounds; Polyethylene Glycols; Solubility; Suspensions; Vitamin E | 2011 |
Evaluation of protein stability and in vitro permeation of lyophilized polysaccharides-based microparticles for intranasal protein delivery.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Absorption; Administration, Intranasal; beta-Cyclodextrins; Chitosan; Freeze Drying; Humans; Hypromellose Derivatives; Methylcellulose; Muramidase; Nasal Mucosa; Particle Size; Polyethylene Glycols; Powders; Primary Cell Culture; Protein Stability; Succinates; Vitamin E | 2011 |
A comparative study of vitamin E TPGS/HPMC supersaturated system and other solubilizer/polymer combinations to enhance the permeability of a poorly soluble drug through the skin.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Crystallization; Drug Stability; Hypromellose Derivatives; Ibuprofen; In Vitro Techniques; Membranes, Artificial; Methylcellulose; Particle Size; Permeability; Poloxamer; Polyethylene Glycols; Povidone; Propylene Glycol; Skin; Skin Absorption; Solubility; Solvents; Swine; Vitamin E | 2012 |
Design and characterization of submicron formulation for a poorly soluble drug: the effect of Vitamin E TPGS and other solubilizers on skin permeability enhancement.
Topics: Administration, Cutaneous; Crystallization; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Stability; Drug Storage; Excipients; Hypromellose Derivatives; Ibuprofen; Methylcellulose; Particle Size; Permeability; Poloxamer; Polyethylene Glycols; Povidone; Skin Absorption; Solubility; Thermodynamics; Vitamin E | 2012 |
Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology.
Topics: 1-Octanol; Dioctyl Sulfosuccinic Acid; Drug Compounding; Drug Stability; Hypromellose Derivatives; Methylcellulose; Molecular Weight; Nanoparticles; Naproxen; Pharmaceutical Preparations; Poloxamer; Polyethylene Glycols; Sodium Dodecyl Sulfate; Solubility; Surface-Active Agents; Suspensions; Transition Temperature; Vitamin E; Water | 2013 |
Supersaturatable formulations for the enhanced oral absorption of sirolimus.
Topics: Absorption; Administration, Oral; Animals; Biological Availability; Drug Compounding; Excipients; Hypromellose Derivatives; Immunosuppressive Agents; Male; Methylcellulose; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Sirolimus; Sucrose; Vitamin E | 2013 |
Development of amorphous solid dispersion formulations of a poorly water-soluble drug, MK-0364.
Topics: Amides; Animals; Cannabinoid Receptor Agonists; Excipients; Hexoses; Macaca mulatta; Methylcellulose; Polyethylene Glycols; Polysorbates; Pyridines; Pyrrolidines; Solubility; Surface-Active Agents; Vinyl Compounds; Vitamin E; Water | 2013 |